Literature DB >> 29737521

Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver.

Deepak Kumar Bhatt1, Aanchal Mehrotra1, Andrea Gaedigk2, Revathi Chapa1, Abdul Basit1, Haeyoung Zhang1, Prachi Choudhari1, Mikael Boberg1,3, Robin E Pearce2, Roger Gaedigk2, Ulrich Broeckel4, J Steven Leeder2, Bhagwat Prasad1.   

Abstract

The ontogeny of hepatic uridine diphosphate-glucuronosyltransferases (UGTs) was investigated by determining their protein abundance in human liver microsomes isolated from 136 pediatric (0-18 years) and 35 adult (age >18 years) donors using liquid chromatography / tandem mass spectrometry (LC-MS/MS) proteomics. Microsomal protein abundances of UGT1A1, UGT1A4, UGT1A6, UGT1A9, UGT2B7, and UGT2B15 increased by ∼8, 55, 35, 33, 8, and 3-fold from neonates to adults, respectively. The estimated age at which 50% of the adult protein abundance is observed for these UGT isoforms was between 2.6-10.3 years. Measured in vitro activity was generally consistent with the protein data. UGT1A1 protein abundance was associated with multiple single nucleotide polymorphisms exhibiting noticeable ontogeny-genotype interplay. UGT2B15 rs1902023 (*2) was associated with decreased protein activity without any change in protein abundance. Taken together, these data are invaluable to facilitate the prediction of drug disposition in children using physiologically based pharmacokinetic modeling as demonstrated here for zidovudine and morphine.
© 2018, The American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29737521      PMCID: PMC6222000          DOI: 10.1002/cpt.1109

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  50 in total

1.  Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates.

Authors:  Karel Allegaert; Jan de Hoon; Rene Verbesselt; Christine Vanhole; Hugo Devlieger; Dick Tibboel
Journal:  Acta Paediatr       Date:  2005-09       Impact factor: 2.299

Review 2.  Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors.

Authors:  Karl Walter Bock
Journal:  Biochem Pharmacol       Date:  2012-07-20       Impact factor: 5.858

3.  The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver.

Authors:  Shogo J Miyagi; Abby C Collier
Journal:  Drug Metab Dispos       Date:  2011-01-25       Impact factor: 3.922

4.  Human hepatic UGT2B15 developmental expression.

Authors:  Karthika Divakaran; Ronald N Hines; D Gail McCarver
Journal:  Toxicol Sci       Date:  2014-06-30       Impact factor: 4.849

5.  Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

6.  Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers.

Authors:  Sasitorn Aueviriyavit; Tomomi Furihata; Kaori Morimoto; Kaoru Kobayashi; Kan Chiba
Journal:  Drug Metab Pharmacokinet       Date:  2007-10       Impact factor: 3.614

7.  In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.

Authors:  Oranun Kerdpin; Kathleen M Knights; David J Elliot; John O Miners
Journal:  Biochem Pharmacol       Date:  2008-05-01       Impact factor: 5.858

8.  The Promises of Quantitative Proteomics in Precision Medicine.

Authors:  Bhagwat Prasad; Marc Vrana; Aanchal Mehrotra; Katherine Johnson; Deepak Kumar Bhatt
Journal:  J Pharm Sci       Date:  2016-12-08       Impact factor: 3.534

9.  Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study.

Authors:  Bhagwat Prasad; Deepak Kumar Bhatt; Katherine Johnson; Revathi Chapa; Xiaoyan Chu; Laurent Salphati; Guangqing Xiao; Caroline Lee; Cornelis E C A Hop; Anita Mathias; Yurong Lai; Mingxiang Liao; William G Humphreys; Sean C Kumer; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2018-04-25       Impact factor: 3.922

10.  Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.

Authors:  B Prasad; A Gaedigk; M Vrana; R Gaedigk; J S Leeder; L Salphati; X Chu; G Xiao; Ceca Hop; R Evers; L Gan; J D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2016-08-13       Impact factor: 6.875

View more
  26 in total

1.  Age-Related Changes in miRNA Expression Influence GSTZ1 and Other Drug Metabolizing Enzymes.

Authors:  Stephan C Jahn; Lauren A Gay; Claire J Weaver; Rolf Renne; Taimour Y Langaee; Peter W Stacpoole; Margaret O James
Journal:  Drug Metab Dispos       Date:  2020-05-01       Impact factor: 3.922

2.  Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper.

Authors:  Bhagwat Prasad; Brahim Achour; Per Artursson; Cornelis E C A Hop; Yurong Lai; Philip C Smith; Jill Barber; Jacek R Wisniewski; Daniel Spellman; Yasuo Uchida; Michael A Zientek; Jashvant D Unadkat; Amin Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2019-07-26       Impact factor: 6.875

3.  Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats.

Authors:  Yifan Tu; Lu Wang; Yi Rong; Vincent Tam; Taijun Yin; Song Gao; Rashim Singh; Ming Hu
Journal:  Elife       Date:  2021-07-01       Impact factor: 8.140

4.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

5.  Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7-18 Years.

Authors:  Haeyoung Zhang; Abdul Basit; Chris Wolford; Kuan-Fu Chen; Andrea Gaedigk; Yvonne S Lin; J Steven Leeder; Bhagwat Prasad
Journal:  Clin Pharmacol Ther       Date:  2020-02-12       Impact factor: 6.875

Review 6.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

7.  Interindividual Variability and Differential Tissue Abundance of Mitochondrial Amidoxime Reducing Component Enzymes in Humans.

Authors:  Deepak Ahire; Abdul Basit; Lisa J Christopher; Ramaswamy Iyer; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2021-12-23       Impact factor: 3.922

8.  Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism.

Authors:  Mayur K Ladumor; Deepak Kumar Bhatt; Andrea Gaedigk; Sheena Sharma; Aarzoo Thakur; Robin E Pearce; J Steven Leeder; Michael B Bolger; Saranjit Singh; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2019-05-17       Impact factor: 3.922

Review 9.  No population left behind: Improving paediatric drug safety using informatics and systems biology.

Authors:  Nicholas P Giangreco; Jonathan E Elias; Nicholas P Tatonetti
Journal:  Br J Clin Pharmacol       Date:  2021-01-19       Impact factor: 3.716

10.  Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling.

Authors:  Laurens F M Verscheijden; Jan B Koenderink; Saskia N de Wildt; Frans G M Russel
Journal:  Arch Toxicol       Date:  2021-07-15       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.